These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9926242)

  • 1. Current clinical trials for the treatment of adult Hodgkin's disease: common strategies and perspectives.
    Wolf J; Tesch H; Parsa-Parsi R; Engert A; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S79-82. PubMed ID: 9926242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.
    Schellong G
    Ann Oncol; 1996; 7 Suppl 4():67-72. PubMed ID: 8836413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Engert A; Diehl V
    Ann Oncol; 2000; 11 Suppl 1():81-5. PubMed ID: 10707785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of radiotherapy for early stage Hodgkin's disease: limitations and perspectives.
    Cosset JM; Mauch PM
    Ann Oncol; 1998; 9 Suppl 5():S57-62. PubMed ID: 9926238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
    Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-stage Hodgkin's disease.
    Josting A; Diehl V
    Curr Oncol Rep; 2001 May; 3(3):279-84. PubMed ID: 11296140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current clinical trials in Hodgkin's disease.
    Reuss K; Engert A; Tesch H; Diehl V
    Ann Oncol; 1996; 7 Suppl 4():109-13. PubMed ID: 8836421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy in early stage Hodgkin's disease: principles and results of recent clinical trials.
    Noordijk EM
    Ann Oncol; 1998; 9 Suppl 5():S63-5. PubMed ID: 9926239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of early clinically staged Hodgkin's disease with a combination of ABVD chemotherapy plus limited field radiotherapy.
    Karmiris TD; Grigoriou E; Tsantekidou M; Spanou E; Mihalakeas H; Baltadakis J; Apostolidis J; Pagoni M; Karakasis D; Bakiri M; Mitsouli C; Harhalakis N; Nikiforakis E
    Leuk Lymphoma; 2003 Sep; 44(9):1523-8. PubMed ID: 14565654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
    Loeffler M; Diehl V; Pfreundschuh M; Rühl U; Hasenclever D; Nisters-Backes H; Sieber M; Tesch H; Franklin J; Geilen W; Bartels H; Cartoni C; Dölken G; Enzian J; Fuchs R; Gassmann W; Gerhartz H; Hagen-Aukamp U; Hiller E; Hinkelbein H; Hinterberger W; Kirchner H; Koch P; Krüger B; Schwarze EW
    J Clin Oncol; 1997 Jun; 15(6):2275-87. PubMed ID: 9196141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation.
    Horning SJ; Hoppe RT; Mason J; Brown BW; Hancock SL; Baer D; Rosenberg SA
    J Clin Oncol; 1997 May; 15(5):1736-44. PubMed ID: 9164180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues in the treatment of Hodgkin's disease.
    Wolf J; Engert A; Diehl V
    Curr Opin Oncol; 1998 Sep; 10(5):396-402. PubMed ID: 9800108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.
    Schellong G; Pötter R; Brämswig J; Wagner W; Prott FJ; Dörffel W; Körholz D; Mann G; Rath B; Reiter A; Weissbach G; Riepenhausen M; Thiemann M; Schwarze EW
    J Clin Oncol; 1999 Dec; 17(12):3736-44. PubMed ID: 10577845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's disease.
    Diehl V; Josting A
    Cancer J; 2000 Apr; 6 Suppl 2():S150-8. PubMed ID: 10803830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [the role of radiotherapy for limited stage Hodgkin's disease in 1999: limitations and perspectives].
    Cosset JM; Fermé C; Henry-Amar M; Carde P
    Cancer Radiother; 1999; 3(2):112-8. PubMed ID: 10230370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82].
    Schellong G; Brämswig J; Ludwig R; Gerein V; Jobke A; Jürgens H; Kabisch H; Stollmann B; Weinel P; Gadner H
    Klin Padiatr; 1986; 198(3):137-46. PubMed ID: 3523020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
    von Tresckow B; Kreissl S; Goergen H; Bröckelmann PJ; Pabst T; Fridrik M; Rummel M; Jung W; Thiemer J; Sasse S; Bürkle C; Baues C; Diehl V; Engert A; Borchmann P;
    Lancet Haematol; 2018 Oct; 5(10):e462-e473. PubMed ID: 30290903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Hodgkin's disease: treatment in the late 1990s.
    Schellong G
    Ann Oncol; 1998; 9 Suppl 5():S115-9. PubMed ID: 9926249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.